tradingkey.logo
搜尋

Xtant Medical Holdings Inc

XTNT
添加自選
0.420USD
-0.001-0.24%
收盤 07/01, 16:00美東報價延遲15分鐘
58.91M總市值
31.91本益比TTM

Xtant Medical Holdings Inc

0.420
-0.001-0.24%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.24%

5天

-2.33%

1月

-9.13%

6月

-46.43%

今年開始到現在

-46.43%

1年

-41.26%

關鍵數據
0.430今開
0.438最高
58.83K成交量
31.91本益比TTM
虧損本益比動
--股利TTM
0.04%換手率
0.421昨收
0.420最低
19.90K成交額
虧損本益比靜
1.15市淨率
0.00%股息率 TTM
2.10%ROA
0.95052週最高
1.57量比
-16.45M淨利潤
140.04M總股本
0.0132每股盈餘TTM
-0.15Beta
3.95%ROE
0.43852週最低
4.25%振幅
57.32%毛利率
58.91M總市值
-2.41回報/風險
3.92%風險率

TradingKey Xtant Medical Holdings Inc股票評分

單位: USD 更新時間: 2026-07-01

操作建議

Xtant Medical Holdings Inc當前公司基本面數據相對非常健康,增長潛力較大。當前估值合理,在醫療設備與耗材行業排名82/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為1.23。中期看,股價處於平穩狀態。近一個月,市場表現較差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Xtant Medical Holdings Inc評分

相關信息

行業排名
82 / 204
全市場排名
216 / 4564
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Xtant Medical Holdings Inc亮點

亮點風險
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.
業績高增長
公司營業收入穩步增長,連續3年增長46.68%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入133.93M美元
業績轉盈
公司業績轉盈,最新年度盈利美元
估值合理
公司最新PE估值31.91,處於3年歷史合理位
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉0.00股
活躍度降低
近期活躍度降低,過去20天平均換手率-0.42

分析師目標

基於 3 分析師
買入
評級
1.233
目標均價
+192.95%
漲幅空間

Xtant Medical Holdings Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Xtant Medical Holdings Inc簡介

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.
公司代碼XTNT
公司Xtant Medical Holdings Inc
CEOBrowne (Sean E)
網址https://xtantmedical.com/

常見問題

Xtant Medical Holdings Inc(XTNT)的當前股價是多少?

Xtant Medical Holdings Inc(XTNT)的當前股價是 0.42。

Xtant Medical Holdings Inc 的股票代碼是什麼?

Xtant Medical Holdings Inc的股票代碼是XTNT。

Xtant Medical Holdings Inc股票的52週最高點是多少?

Xtant Medical Holdings Inc股票的52週最高點是0.95。

Xtant Medical Holdings Inc股票的52週最低點是多少?

Xtant Medical Holdings Inc股票的52週最低點是0.44。

Xtant Medical Holdings Inc的市值是多少?

Xtant Medical Holdings Inc的市值是58.82M。

現在Xtant Medical Holdings Inc(XTNT)的股票是買入、持有還是賣出?

根據分析師評級,Xtant Medical Holdings Inc(XTNT)的總體評級為買入,目標價格為1.23。

Xtant Medical Holdings Inc(XTNT)股票的每股收益(EPS TTM)是多少

Xtant Medical Holdings Inc(XTNT)股票的每股收益(EPS TTM)是0.04。